Steroid Premedication Might Protect From Postoperative Erythema Nodosum Leprosum in Leprosy: A Case ReportPreventive Medicine Published on 2024-03-112024-09-05 Journal: Cureus [Category] update2024, [키워드] drug-related side effects and adverse reactions Hansen’s disease Immune-mediated inflammatory diseases multi drug therapy postoperative complicaiton type 2 lepra reaction [DOI] 10.7759/cureus.55986 PMC 바로가기 [Article Type] Preventive Medicine
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activityarticle Published on 2023-05-172024-09-05 Journal: BMC Infectious Diseases [Category] update2024, [키워드] antibodies Autoimmune disease COVID-19 Disease activity flare Immune-mediated inflammatory diseases Immunity Immunosuppression SARS-CoV-2 TNF [DOI] 10.1186/s12879-023-08298-6 PMC 바로가기 [Article Type] article
Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the NetherlandsShort Report Published on 2023-01-192024-09-05 Journal: Molecular pharmacology [Category] update2024, [키워드] adherence Biological Immune-mediated inflammatory diseases SARS-CoV-2 [DOI] 10.2147/PPA.S392290 PMC 바로가기 [Article Type] Short Report
Cytokines and cytokine receptors as targets of immune-mediated inflammatory diseases—RA as a role modelarticle Published on 2022-12-012024-09-02 Journal: Inflammation and Regeneration [Category] 대상포진, [키워드] Biological agents cytokine cytokine receptor Immune-mediated inflammatory diseases jak inhibitors [DOI] 10.1186/s41232-022-00221-x PMC 바로가기 [Article Type] article
Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapyB세포 고갈 요법으로 치료받은 환자에서 BNT162b2 mRNA COVID-19 백신 3차 접종에 대한 체액 및 세포 반응 평가Article Published on 2022-07-012022-09-11 Journal: Journal of autoimmunity [Category] MERS, 바이오마커, 유전자 메커니즘, 진단, [키워드] affected anti-CD20 anti-S anti-SARS-CoV-2 antibody Autoimmune disease B-cell BNT162b2 CD-20 CD20 cellular immunity cellular response Cohort COVID-19 COVID-19 vaccination COVID-19 vaccine depleting dose doses drug group healthy control healthy controls humoral humoral and cellular immunity IFN-g IgG IMID Immune-mediated inflammatory disease Immune-mediated inflammatory diseases immunogenic immunogenicity Immunosuppressed immunosuppressed patient immunosuppressed patients Inflammatory diseases interferon mRNA mRNA COVID-19 vaccine mRNA COVID-19 vaccines naïve Neutralization assay neutralization assays neutralization titer neutralization titers Neutralizing antibodies neutralizing antibody no significant difference of BNT162b2 Patient patients treated Quantitative reduced response seroconverted significant difference significantly spike subject therapy These data treated vaccination [DOI] 10.1016/j.jaut.2022.102848 PMC 바로가기 [Article Type] Article
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trialResearch article Published on 2022-06-272022-10-05 Journal: The Lancet. Respiratory Medicine [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 임상, 치료법, [키워드] 1:1 95% CI administration age Analysis Antibody Response Antibody titre Arthritis assigned atopic dermatitis booster Booster vaccine clinics COVID-19 COVID-19 vaccination COVID-19 vaccination programme COVID-19 vaccine data analyst Dermatology diagnosed domain dose Effect Efficacy evaluated female finding funding geometric geometric mean ratio GMR groups hospital Immune-mediated Immune-mediated inflammatory disease Immune-mediated inflammatory diseases Immunity inflammatory condition inflammatory disease inhibit intention-to-treat population interim analysis Intervention investigators Laboratory low-dose methotrexate mixed-effects model multicentre open label Open-label parallel-group participant Participants Patient platform Primary outcome randomisation randomised Randomly receiving recruited recruitment Registered Research researcher rheumatoid arthritis rheumatology SARS-CoV-2 SARS-COV-2 infection Serious Adverse Events Spike protein spondyloarthritis susceptible systemic lupus erythematosus the SARS-CoV-2 translate Treatment treatment as usual Trial Two-arm vaccination Vaccine vaccine dose Vaccine-induced immunity [DOI] 10.1016/S2213-2600(22)00186-2 [Article Type] Research article
Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases면역 매개 염증성 질환 환자에서 SARS-CoV-2 mRNA 백신에 대한 면역 약화 가속화Observational Study Published on 2022-06-082022-09-11 Journal: JCI Insight [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단, 치료기술, [키워드] Adaptive immunity Adult patients All participants ankylosing spondylitis anti-TNF Arthritis attrition Autoimmune diseases azathioprine COVID-19 COVID-19 vaccination declining disease donation dose Efficacy examined force greater healthy control healthy controls Immune-mediated inflammatory disease Immune-mediated inflammatory diseases Immunity immunogenicity immunology Immunosuppressant immunosuppressants immunosuppressive therapies Immunotherapy Inflammatory bowel disease Inflammatory diseases information Juan methotrexate mRNA vaccine neutralization Observational cohort study omicron Participants Patient rapid response rheumatoid arthritis SARS-CoV-2 SARS-CoV-2 variants Speck spondylitis subjects Support T cell T cell response Task Force Treatment undetectable Vaccine variants variants of concern [DOI] 10.1172/jci.insight.159721 PMC 바로가기 [Article Type] Observational Study
Characteristics of patients with immune-mediated inflammatory diseases hospitalized for SARS-CoV-2 infectionArticle Published on 2022-06-012023-07-06 Journal: Reumatología clinica [Category] COVID19(2023년), [키워드] COVID-19 Enfermedades inflamatorias Inmunomediadas Hospitalización Hospitalization IMID Immune-mediated inflammatory diseases Infección por SARS-CoV-2 SARS-COV-2 infection [DOI] 10.1016/j.reumae.2021.03.005 PMC 바로가기
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients아달리무맙과 인플릭시맙은 SARS-CoV-2 항체 반응을 손상시킨다: 생물학적 치료를 받은 11,422명의 환자를 대상으로 한 치료 약물 모니터링 연구의 결과Article Published on 2022-03-142022-09-11 Journal: Journal of Crohn's & colitis [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] adalimumab anti-TNF antibody reactivity Antibody Response Antibody testing attenuate biologic bowel causal relationship CLARITY combination therapy confounding factors COVID-19 cut-off detectable drug drug level drug levels drugs Immune-mediated inflammatory diseases immunomodulator Immunosuppression Inflammatory Inflammatory bowel disease Inflammatory diseases infliximab influence Laboratory magnitude median median age median time monitoring Necrosis Patient patients PCR testing PCR-confirmed positive Rate reactivity responses Result SARS-CoV-2 SARS-CoV-2 antibodies SARS-COV-2 infection SARS-CoV-2 nucleocapsid SARS-CoV-2 PCR seroconvert serological serological response seropositive Seropositivity Seroprevalence serum Support therapeutic drug Therapeutic Drug Monitoring treated Treatment treatment groups undetectable vaccination vedolizumab were measured [DOI] 10.1093/ecco-jcc/jjab153 PMC 바로가기 [Article Type] Article
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach류마티스학에서의 Janus kinase-targeting therapy: 메커니즘 기반 접근Review Published on 2022-03-012022-09-12 Journal: Nature reviews. Rheumatology [Category] MERS, SARS, 진단, [키워드] activate Activation adaptive addition allergic approach atopic dermatitis Autoimmune Autoimmune disease autoreactive T cell B cells cytokine Cytokine storm development Diseases disorders downstream effective glucocorticoid immune Immune-mediated inflammatory diseases Immunity Immunosuppressant implicated Inflammatory bowel disease Inflammatory diseases inhibitory Innate immunity involved Jak JAK inhibitor jak inhibitors JAK-STAT pathway janus Janus kinase multiple cytokine non-specific outcome pathology positive profiles Protein receptors rheumatoid arthritis selective Seven Signal transduction spondyloarthritis STAT suppress systemic lupus erythematosus therapy Transcription transcription factor Treatment [DOI] 10.1038/s41584-021-00726-8 PMC 바로가기 [Article Type] Review